- Record: found
- Abstract: found
- Article: not found
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
Nov 16 2010
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study assessed the efficacy and safety of the neuronal potassium channel opener ezogabine (US adopted name; EZG)/retigabine (international nonproprietary name; RTG) as adjunctive therapy for refractory partial-onset seizures.